The effect of hyperhomocysteinemia on the severity of diabetic neuropathy in patients with type 2 diabetes mellitus
AbstractThis article presents of hyperhomocysteinemia on the severity of diabetic neuropathy in patients with type 2 diabetes mellitus.
Keywords:hyperhomocysteinemia, oxidative stress, type 2 diabetes mellitus, diabetic neuropathy
References
1. Tesfaye S., Boulton A.J., Dickenson A.H. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care. 2013; 36: 2456-65.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of Diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-86.
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54: 1615-25.
4. Wang H., Cui K., Xu K., Xu S. Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients. Int J Clin Exp Med. 2015; 8 (7): 11174-80.
5. Li J., Shi M., Zhang H., Yan L., et al. Relation of homocysteine to early nephropathy in patients with type 2 diabetes. Clin Nephrol. 2012; 77 (4): 305-10.
6. Brazionis L., Rowley K., Itsiopoulos C., Harper C.A., O'Dea K. Homocysteine and diabetic retinopathy. Diabetes Care. 2008; 31 (1): 50-6.
7. Rudy A., Kowalska I., Str^czkowski M., Kinalska I. Homocysteine concentrations and vascular complications in patients with type 2 diabetes. Diabetes Metab. 2005; 31 (2): 112-7.
8. Jacobsen D.W. Hyperhomocysteinemia and oxidative stress. Arterioscler Thromb Vasc Biol. 2000; 20: 1182-4.
9. Weiss N., Zhang Y.Y., Heydrick S., Bierl C., Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e) ine-induced endothelial dysfunction. Proc Natl Acad Sci USA. 2001; 98 (22): 12503-8.
10. Hoogeveen E.K., Kostense P.J., Jakobs C., et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation. 2000; 101: 1506-11.